News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Colgate And GlaxoSmithKline To Bid For Pfizer Inc. Unit
March 30, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Pfizer Inc., the No.1 pharmaceutical firm, is expected to receive offers for its consumer-products business from Colgate Palmolive Co. and GlaxoSmithKline Plc in the first rounds of bidding Wednesday, according to a published report.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Pfizer
GlaxoSmithKline
MORE ON THIS TOPIC
Mergers & acquisitions
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover
October 10, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
AviadoBio Looks to China for Eye-Based Gene Therapy in $413M UgeneX Pact
October 10, 2025
·
2 min read
·
Tristan Manalac
Mergers & Acquisitions
Novo Strikes up to $5.2B Deal for Akero in Red-Hot MASH Space
October 9, 2025
·
2 min read
·
Annalee Armstrong
Mergers & acquisitions
Zenas Bets $2B+ in Autoimmune Agreement With Chinese Firm InnoCare
October 8, 2025
·
2 min read
·
Tristan Manalac